| Clinical data | |
|---|---|
| Trade names | Promecon, Quantril, Emete-Con |
| License data | |
| Routes of administration | Suppository, injection |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H32N2O5 |
| Molar mass | 404.507 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.[2] [3]
References
- ↑ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ↑ Scriabine A, Weissman A, Finger KF (1963). "Benzquinamide". JAMA. 184 (4): 276–279. doi:10.1001/jama.1963.73700170001010. ISSN 0098-7484. PMID 13992595.
- ↑ E.I. Goldenthal (1971). "A compilation of LD50 values in newborn and adult animals". Toxicol. Appl. Pharmacol. 18 (1): 185–207. Bibcode:1971ToxAP..18..185G. doi:10.1016/0041-008X(71)90328-0. PMID 5542824.